Skip to main content
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
2.570
-0.010 (-0.39%)
At close: May 3, 2024, 4:00 PM
2.520
-0.050 (-1.95%)
After-hours: May 3, 2024, 6:58 PM EDT

Taysha Gene Therapies Revenue

In the year 2023, Taysha Gene Therapies had annual revenue of $15.45M with 517.55% growth. Revenue in the quarter ending December 31, 2023 was $3.60M with 44.04% year-over-year growth.

Revenue (ttm)
$15.45M
Revenue Growth
+517.55%
P/S Ratio
31.11
Revenue / Employee
$297,135
Employees
52
Market Cap
480.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 20210--
Dec 31, 20200--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TSHA News

More News